Search research articles
Contact Us
Filters
Showing results (1-10 of 28) with videos related to
Page
of 3
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1990
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans
T Thomsen, U Bickel, J P Fischer, et al.
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators
|
December 8, 1997
Building a successful open heart program
K R Alexander, J P Fischer, N R Simpson
Biochemical Pharmacology
|
January 1, 1991
In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers
T Thomsen, B Zendeh, J P Fischer, et al.
Toxicology
|
March 1, 1987
Differential induction of cytochrome P-450 catalyzed activities by polychlorinated biphenyls and benzo [a]pyrene in B6C3F1 mouse liver and lung
C E Mitchell, J P Fischer, A R Dahl
Electroencephalography and Clinical Neurophysiology
|
June 1, 1992
Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials
G Holl, M Straschill, T Thomsen, et al.
Neuropharmacology
|
May 1, 1991
Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice
U Bickel, T Thomsen, J P Fischer, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
February 9, 2019
Hernia prevention: practice patterns and surgeons' attitudes about abdominal wall closure and the use of prophylactic mesh
J P Fischer, H W Harris, M López-Cano, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
September 25, 2014
A comparison of outcomes and cost in VHWG grade II hernias between Rives-Stoppa synthetic mesh hernia repair versus underlay biologic mesh repair
J P Fischer, M N Basta, M N Mirzabeigi, et al.
Archives of Gerontology and Geriatrics
|
January 1, 1994
Atherosclerotic disease in very old age: Preliminary results from the Berlin aging study (base)
R Nieczaj, J P Fischer, M Taupitz, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1991
Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition
U Bickel, T Thomsen, W Weber, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 28) with videos related to
Sort By:
Page
of 3
European Journal of Clinical Pharmacology
|
January 1, 1990
Stereoselectivity of cholinesterase inhibition by galanthamine and tolerance in humans
T Thomsen, U Bickel, J P Fischer, et al.
The Journal of Cardiovascular Management : the Official Journal of the American College of Cardiovascular Administrators
|
December 8, 1997
Building a successful open heart program
K R Alexander, J P Fischer, N R Simpson
Biochemical Pharmacology
|
January 1, 1991
In vitro effects of various cholinesterase inhibitors on acetyl- and butyrylcholinesterase of healthy volunteers
T Thomsen, B Zendeh, J P Fischer, et al.
Toxicology
|
March 1, 1987
Differential induction of cytochrome P-450 catalyzed activities by polychlorinated biphenyls and benzo [a]pyrene in B6C3F1 mouse liver and lung
C E Mitchell, J P Fischer, A R Dahl
Electroencephalography and Clinical Neurophysiology
|
June 1, 1992
Effect of the cholinesterase inhibiting substance galanthamine on human EEG and visual evoked potentials
G Holl, M Straschill, T Thomsen, et al.
Neuropharmacology
|
May 1, 1991
Galanthamine: pharmacokinetics, tissue distribution and cholinesterase inhibition in brain of mice
U Bickel, T Thomsen, J P Fischer, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
February 9, 2019
Hernia prevention: practice patterns and surgeons' attitudes about abdominal wall closure and the use of prophylactic mesh
J P Fischer, H W Harris, M López-Cano, et al.
Hernia : the Journal of Hernias and Abdominal Wall Surgery
|
September 25, 2014
A comparison of outcomes and cost in VHWG grade II hernias between Rives-Stoppa synthetic mesh hernia repair versus underlay biologic mesh repair
J P Fischer, M N Basta, M N Mirzabeigi, et al.
Archives of Gerontology and Geriatrics
|
January 1, 1994
Atherosclerotic disease in very old age: Preliminary results from the Berlin aging study (base)
R Nieczaj, J P Fischer, M Taupitz, et al.
Clinical Pharmacology and Therapeutics
|
October 1, 1991
Pharmacokinetics of galanthamine in humans and corresponding cholinesterase inhibition
U Bickel, T Thomsen, W Weber, et al.
Page
of 3